|
|
EPIDERMAL FACTORS THAT PROMOTE INTERNAL TISSUE PROGENITOR ACTIVATION FOLLOWING AMPUTATION |
| 5R03AR068126-02 |
WHITED, JESSICA L |
NIAMS |
2016 |
|
|
IN VIVO MOLECULAR PROBES FOR THE MEMBRANE REPAIR PATHWAY IN MUSCLE |
| 5R21AR066213-02 |
MICHELE, DANIEL E |
NIAMS |
2016 |
|
|
DEVELOPMENT OF A NOVEL HIBM2 MOUSE MODEL AND THERAPY |
| 5R21AR067366-02 |
MARTIN, PAUL TAYLOR |
NIAMS |
2016 |
|
|
IMPROVING DISABILITY IN KNEE OSTEOARTHRITIS BY TARGETING NEUROMUSCULAR DEFICITS |
| 5R21AR067560-02 |
PIETROSIMONE, BRIAN |
NIAMS |
2016 |
|
|
ANALYSIS OF D4Z4 HETEROCHROMATIN IN FSHD MYOBLAST MODELS |
| 5R21AR067636-02 |
YOKOMORI, KYOKO |
NIAMS |
2016 |
|
|
CCR7 AND ITS LIGANDS IN OSTEOARTHRITIS |
| 5R21AR067916-02 |
SCANZELLO, CARLA ROSE |
NIAMS |
2016 |
|
|
ALLOSTERIC SMALL MOLECULE INHIBITOR OF NERVE GROWTH FACTOR SIGNALING IN LOW BACK PAIN |
| 5R21AR067935-02 |
CHEN, DI |
NIAMS |
2016 |
|
|
A C. ELEGANS DRUG DISCOVERY PLATFORM FOR DYSFERLIN-BASED MUSCULAR DYSTROPHIES |
| 5R21AR068477-02 |
GUARENTE, LEONARD P |
NIAMS |
2016 |
|
|
METHODOLOGIC REMEDIES FOR THE RISK FACTOR PARADOX IN OSTEOARTHRITIS PROGRESSION |
| 5R21AR068493-02 |
CHOI, HYON K |
NIAMS |
2016 |
|
|
USING THE DMD ZEBRAFISH ANIMAL MODEL FOR IDENTIFYING DRUG COMBINATION THERAPIES AND BIOMARKERS |
| 5R21AR068536-02 |
MAVES, LISA A |
NIAMS |
2016 |
